Search Results - "Morrison, Tara"

Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency by Morris, Andrew A. M., Kožich, Viktor, Santra, Saikat, Andria, Generoso, Ben-Omran, Tawfeg I. M., Chakrapani, Anupam B., Crushell, Ellen, Henderson, Mick J., Hochuli, Michel, Huemer, Martina, Janssen, Miriam C. H., Maillot, Francois, Mayne, Philip D., McNulty, Jenny, Morrison, Tara M., Ogier, Helene, O’Sullivan, Siobhan, Pavlíková, Markéta, de Almeida, Isabel Tavares, Terry, Allyson, Yap, Sufin, Blom, Henk J., Chapman, Kimberly A.

“…Cystathionine beta-synthase (CBS) deficiency is a rare inherited disorder in the methionine catabolic pathway, in which the impaired synthesis of cystathionine…”
Get full text

TIF1 activates the intra-S-phase checkpoint response in the diploid micronucleus and amitotic polyploid macronucleus of Tetrahymena by Yakisich, J Sebastian, Sandoval, Pamela Y, Morrison, Tara L, Kapler, Geoffrey M

“…The ribosomal DNA origin binding protein Tif1p regulates the timing of rDNA replication and is required globally for proper S-phase progression and division of…”
Get full text

Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule by Perry, James R., Rizek, Philippe, Cashman, Rosemary, Morrison, Meredith, Morrison, Tara

“…BACKGROUND. Despite advances in first‐line therapy, there are few data on treatment of glioblastoma multiforme (GBM) at recurrence. Temozolomide (TMZ) is well…”
Get full text

TIF1 Represses rDNA replication initiation, but promotes normal S phase progression and chromosome transmission in Tetrahymena by Morrison, Tara L, Yakisich, J Sebastian, Cassidy-Hanley, Donna, Kapler, Geoffrey M

“…The non-ORC protein, TIF1, recognizes sequences in the Tetrahymena thermophila ribosomal DNA (rDNA) minichromosome that are required for origin activation. We…”
Get full text

A review of the symptomatic management of malignant gliomas in adults by Shah, Umang, Morrison, Tara

“…Malignant brain tumors are aggressive tumors with a very poor prognosis. Survival is on average 12 to 18 months. Patients with malignant gliomas are subject to…”
Get more information

New graduates’ experience of evidence-based practice: An action research study by Morrison, Tara, Robertson, Linda

“…Introduction The aim of this project was to explore how occupational therapy graduates in New Zealand engaged with evidence-based practice. Method The study…”
Get full text

Does the use of complementary and alternative medicine (CAM) influence survival in glioblastoma multiforme? by Ambady, Prakash, Morrison, Tara

“…Abstract only e12509 Background: Glioblastoma multiforme (GBM) is a devastating CNS tumor with an incidence of around 14,000 per year in the USA. Patients…”
Get full text

Bony metastases of anaplastic oligodendroglioma respond to temozolomide by Morrison, Tara, Bilbao, Juan M, Yang, Guisheng, Perry, James R

“…Fewer than 30 cases of oligodendroglioma or anaplastic oligodendroglioma metastatic to bone are reported in the literature. Prolonged survival even with…”
Get more information

Temozolomide Rechallenge in Recurrent Malignant Glioma by Using a Continuous Temozolomide Schedule : The Rescue Approach by PERRY, James R, RIZEK, Philippe, CASHMAN, Rosemary, MORRISON, Meredith, MORRISON, Tara

“…Despite advances in first-line therapy, there are few data on treatment of glioblastoma multiforme (GBM) at recurrence. Temozolomide (TMZ) is well tolerated…”
Get full text

Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations by Brastianos, Priscilla K, Twohy, Erin L, Gerstner, Elizabeth R, Kaufmann, Timothy J, Iafrate, A John, Lennerz, Jochen, Jeyapalan, Suriya, Piccioni, David E, Monga, Varun, Fadul, Camilo E, Schiff, David, Taylor, Jennie W, Chowdhary, Sajeel A, Bettegowda, Chetan, Ansstas, George, De La Fuente, Macarena, Anderson, Mark D, Shonka, Nicole, Damek, Denise, Carrillo, Jose, Kunschner-Ronan, Lara J, Chaudhary, Rekha, Jaeckle, Kurt A, Senecal, Francis M, Kaley, Thomas, Morrison, Tara, Thomas, Alissa A, Welch, Mary R, Iwamoto, Fabio, Cachia, David, Cohen, Adam L, Vora, Shivangi, Knopp, Michael, Dunn, Ian F, Kumthekar, Priya, Sarkaria, Jann, Geyer, Susan, Carrero, Xiomara W, Martinez-Lage, Maria, Cahill, Daniel P, Brown, Paul D, Giannini, Caterina, Santagata, Sandro, Barker, 2nd, Frederick G, Galanis, Evanthia

“…Patients with progressive or recurrent meningiomas have limited systemic therapy options. Focal adhesion kinase (FAK) inhibition has a synthetic lethal…”
Get full text

CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA by Grommes, Christian, Mehta, Minesh, Miller, Alexandra, Daras, Mariza, Piotrowski, Anna, Boire, Adrienne, Butler, Brittany, Stone, Jacqueline, Pentsova, Elena, Kotecha, Rupesh, Morrison, Tara, Odia, Yazmin, Mellinghoff, Ingo, Beal, Kathryn

“…Abstract Standard of standard of care for glioblastoma (GBM) remains unsatisfactory with universal disease recurrence and a median survival of < 2 years…”
Get full text

Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations by Brastianos, Priscilla Kaliopi, Twohy, Erin, Gerstner, Elizabeth Robins, Kaufmann, Timothy J., Iafrate, A. John, Jeyapalan, Suriya A., Piccioni, David Eric, Lassman, Andrew B., Fadul, Camilo E., Schiff, David, Taylor, Jennie Webster, Chowdhary, Sajeel A., Kaley, Thomas Joseph, Morrison, Tara, Kumthekar, Priya, Geyer, Susan, Cahill, Daniel P., Santagata, Sandro, Barker, Frederick G., Galanis, Evanthia

“…Abstract only 2502 Background: Patients with progressive or recurrent meningiomas have limited treatment options. Clinical trials of systemic therapies for…”
Get full text

CTNI-55. THE CDK4/6 INHIBITOR ABEMACICLIB IN PATIENTS WITH RECURRENT MENINGIOMA AND OTHER PRIMARY CNS TUMORS by Coffee, Elizabeth, Panageas, Katherine, Young, Robert, Morrison, Tara, Daher, Ahmad, Grommes, Christian, Gavrilovic, Igor T, Lin, Andrew, Miller, Alexandra, Schaff, Lauren, Daras, Mariza, DeAngelis, Lisa, Diamond, Eli, Piotrowski, Anna, Malani, Rachna, Nolan, Craig, Pentsova, Elena, Santomasso, Bianca, Stone, Jacqueline, Nair, Suresh, Mellinghoff, Ingo K, Kaley, Thomas

“…Abstract BACKGROUND Medical therapies for recurrent brain tumors are limited. Abemaciclib is a small molecule CDK4/6 inhibitor that has demonstrated antitumor…”
Get full text

Simultaneous peripheral facial palsies (SPFP) and bilateral foot drops after initiation of eribulin in a patient with triple-negative breast cancer by Morrison, Tara, Swaby, Ramona F., Ryan, Paula D., Ambady, Prakash

“…Abstract only e11085 Background: Simultaneous peripheral facial palsy (SPFP) is extremely rare. Unlike Bell’s palsy it is seldom idiopathic. We describe a case…”
Get full text

Central nervous system cancers by Nabors, Louis Burt, Ammirati, Mario, Bierman, Philip J, Brem, Henry, Butowski, Nicholas, Chamberlain, Marc C, DeAngelis, Lisa M, Fenstermaker, Robert A, Friedman, Allan, Gilbert, Mark R, Hesser, Deneen, Holdhoff, Matthias, Junck, Larry, Lawson, Ronald, Loeffler, Jay S, Maor, Moshe H, Moots, Paul L, Morrison, Tara, Mrugala, Maciej M, Newton, Herbert B, Portnow, Jana, Raizer, Jeffrey J, Recht, Lawrence, Shrieve, Dennis C, Sills, Jr, Allen K, Tran, David, Tran, Nam, Vrionis, Frank D, Wen, Patrick Y, McMillian, Nicole, Ho, Maria

“…Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently,…”
Get more information

Central nervous system cancers by Brem, Steven S, Bierman, Philip J, Brem, Henry, Butowski, Nicholas, Chamberlain, Marc C, Chiocca, Ennio A, DeAngelis, Lisa M, Fenstermaker, Robert A, Friedman, Allan, Gilbert, Mark R, Hesser, Deneen, Junck, Larry, Linette, Gerald P, Loeffler, Jay S, Maor, Moshe H, Michael, Madison, Moots, Paul L, Morrison, Tara, Mrugala, Maciej, Nabors, Louis Burt, Newton, Herbert B, Portnow, Jana, Raizer, Jeffrey J, Recht, Lawrence, Shrieve, Dennis C, Sills, Jr, Allen K, Vrionis, Frank D, Wen, Patrick Y

Get more information

Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer by Cole, Marion, Parajuli, Shobha, Laske, Douglas, Goldstein, Lori, Morrison, Tara, Mukherjee, Abir, Tumelty, Kathryn, Tetzlaff, Eric, von Mehren, Margaret, Inniss, Susan

“…Female, 51. Ewing sarcoma. Visual disturbances. -. -. Oncology. Rare disease. Primitive neuroectodermal tumor/Ewing sarcoma (PNET/EWS) is a round blue cell…”
Get full text

MR Imaging and Histologic Features of Capillary Telangiectasia of the Basal Ganglia by Castillo, Mauricio, Morrison, Tara, Shaw, Jo A, Bouldin, Thomas W

“…Capillary telangiectasias are being recognized with increasing frequency on MR imaging studies. Most are located in the brain stem and show slightly increased…”
Get full text

Roles of the Tetrahymena thermophila type I element binding factor, TIF1, in DNA replication and genome stability by Morrison, Tara Laine

“…The Tetrahymena thermophila rDNA minichromosome has been used as a model system for studying DNA replication. Previous studies have identified cis-acting…”
Get full text